Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sugammadex vs Neostigmine in Liver Transplantation
NCT02697929Completed
- Sponsor
- Azienda Ospedaliera di Perugia
- Start
- Jan 2014
- Primary completion
- Jan 2019
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 1
01
Overview
Randomised trial of Sugammadex in neuromuscular blockade (NMB) (2 arms), sponsored by Azienda Ospedaliera di Perugia. Primary endpoint: Recovery time from moderate neuromuscular block to a TOF ratio more than 0.9 at 30 minutes. Started Jan 2014; status: completed.
02
Drugs
Sugammadex
03
Conditions
neuromuscular blockade (NMB)
Beyond the preview
Go deeper on NCT02697929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02697929.